Dr. Natalia Martin Orozco
VP, Providence Therapeutics
Dr. Natalia Martin Orozco serves as the VP of Drug Development for Providence Therapeutics. She leads the research, development and manufacturing team for development of personalized mRNA vaccines.
Dr. Martin, came from the United States, where she worked leading teams in big pharmaceuticals, such as EMD Serono as well as small biotech companies such as Iovance and Bellicum Pharmaceuticals. She had developed biologics and drugs for the treatment of Inflammatory diseases and cancer from proof of concept to IND and Phase I trials. She also has developed personalized cell therapies for cancer patients where she took the program to approved INDs.